Bilateral evolution of OCT biomarkers in dry AMD: Long-term follow up study.
Anindya SamantaSupriya AroraMahima JhinganSumit SinghSohani AmarasekeraDavide TucciCarlo CaginiMarco LupidiJay ChhablaniPublished in: European journal of ophthalmology (2023)
Late-stage OCT biomarkers are seen bilaterally at 21.9% at baseline and at 56.3% at 5.8 years follow-up. Once present in one eye, cRORA had the shortest mean interval before appearance in the other eye.